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abstract
 
Retinal pigment epithelial (RPE) cells mediate the recognition and clearance of effete photoreceptor
outer segments (POS), a process central to the maintenance of normal vision. Given the emerging importance of
Toll-like receptors (TLRs) in transmembrane signaling in response to invading pathogens as well as endogenous
substances, we hypothesized that TLRs are associated with RPE cell management of POS. TLR4 clusters on human
RPE cells in response to human, but not bovine, POS. However, TLR4 clustering could be inhibited by saturating
concentrations of an inhibitory anti-TLR4 mAb. Furthermore, human POS binding to human RPE cells elicited
transmembrane metabolic and calcium signals within RPE cells, which could be blocked by saturating doses of an
inhibitory anti-TLR4 mAb. However, the heterologous combination of bovine POS and human RPE did not trigger
these signals. The pattern recognition receptor CD36 collected at the POS–RPE cell interface for both homologous
and heterologous samples, but human TLR4 only collected at the human POS–human RPE cell interface. Kinetic
experiments of human POS binding to human RPE cells revealed that CD36 arrives at the POS–RPE interface
followed by TLR4 accumulation within 2 min. Metabolic and calcium signals immediately follow. Similarly, the
production of reactive oxygen metabolites (ROMs) was observed for the homologous human system, but not the
heterologous bovine POS–human RPE cell system. As (a) the bovine POS/human RPE combination did not elicit
TLR4 accumulation, RPE signaling, or ROM release, (b) TLR4 arrives at the POS–RPE cell interface just before
signaling, (c) TLR4 blockade with an inhibitory anti-TLR4 mAb inhibited TLR4 clustering, signaling, and ROM
release in the human POS–human RPE system, and (d) TLR4 demonstrates similar clustering and signaling responses
to POS in conﬂuent RPE monolayers, we suggest that TLR4 of RPE cells participates in transmembrane signaling
events that contribute to the management of human POS.
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INTRODUCTION
 
Toll
 
 is a family of eight genes whose products are pattern
recognition proteins that contribute to establishing the
dorsal–ventral axis during embryogenesis and trigger
the synthesis of antimicrobial peptides in 
 
Drosophila
 
(Akira, 2000; Schuster and Nelson, 2000; Dobrovolskaia
and Vogel, 2002). Janeway’s group ﬁrst cloned human
homologues of toll (Toll-like receptors [TLRs]) and
demonstrated their relevance to adaptive immunity
(Medzhitov et al., 1997). Human TLRs represent a family
of over a dozen proteins mediating the recognition of
molecules such as lipopolysaccharide (LPS), lipoteichoic
acid, bacterial lipoprotein, zymosan, peptidoglycan,
ﬂagellin, and bacterial DNA (Akira, 2000; Dobrovolskaia
and Vogel, 2002; Barton and Medzhitov, 2002). TLRs
are type I transmembrane proteins characterized by
extracellular leucine-rich repeats and an intracellular
region homologous to the internal domain of the inter-
leukin-1 receptor. They are expressed by many immune
cells including neutrophils, macrophages, monocytes,
mast cells, dendritic cells, T cells, and B cells (e.g.,
Schuster and Nelson, 2000; Termeer et al., 2002; Do-
brovolskaia and Vogel, 2002). The cellular signaling
mechanisms of TLRs and IL-1 receptors are similar and
lead to changes in cytokine expression. Although a
great deal of interest has been focused on the role of
TLRs in leukocyte responses to microbes and their
by-products, TLRs may be more broadly used in meta-
zoans. Recent work has shown that TLRs are expressed
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by several cell types, including leukocytes, endothelial
cells, intestinal epithelial cells, corneal cells, and others
(e.g., Song et al., 2001; Hornef et al., 2002). Further-
more, TLR expression has been identiﬁed in several
types of tissues (e.g., heart, brain, placenta, ovary, pros-
tate, muscle, etc.) (Schuster and Nelson, 2000).
In addition to neutrophils and monocytes/macro-
phages, retinal pigment epithelial (RPE) cells are also
“professional” phagocytes. RPE cells lay between the
choroid and photoreceptor cells of the neurosensory
retina. The photoreceptors must constantly shed aged
or damaged portions of their outer segments (POS).
Several proteins may participate in the clearance of
POS. MERTK, which is also known as the proto-onco-
gene c-mer, is a key participant in the phagocytosis of
POS, as illustrated by genetic studies (D’Cruz et al.,
2000; Gal et al., 2000). In addition, the pattern recogni-
tion receptor CD36 and the integrin 
 
 
 
V
 
 
 
5
 
 have also
been suggested to participate in POS clearance (Finne-
mann et al., 1997; Finnemann and Silverstein, 2001).
As leukocyte TLRs appear to play key roles in signaling
but not phagocytosis, we postulated that TLRs partici-
pate in the handling of POS by RPE cells. In the
present study we show that TLR4 molecules expressed
at the surface of human RPE cells participate in the cel-
lular handling of human POS.
 
MATERIALS AND METHODS
 
Reagents and Antibodies
 
FITC, TRITC, and indo-1 were obtained from Molecular Probes.
Anti-CD36 was obtained from PharMingen. Anti-TLR4 was a gift
of K. Miyake (Saga Medical School, Saga, Japan) (Shimazu et al.,
1999). FITC or TRITC-conjugated antibodies were prepared as
previously described (Kindzelskii et al., 1997).
 
RPE Cell and POS Preparation
 
Human RPE cells were isolated from donor eyes as previously de-
scribed (Elner et al., 1991). Primary, ﬁrst, or second passaged hu-
man RPE cells were trypsinized and then seeded onto glass cover-
slips 5 d before experiments. Bovine and human eyes were ob-
tained, neural retina were removed, and then POS were obtained
from retinal homogenates by sucrose density gradient centrifuga-
tion (Uhl et al., 1987). POS were ﬂuorescently labeled with FITC
by the method of McLaren et al. (1993). For experimental use, a
stock POS solution at 5 
 
 
 
 10
 
6
 
 particles/ml was diluted to give a
10:1 ratio of POS to cells.
 
RT-PCR
 
Synthetic oligonucleotide primers based on the cDNA sequences
of human TLR4 and 
 
 
 
-actin were prepared: TLR4, 5
 
 
 
-TCCCTC-
CAGGTTCTTGATTACAGTC-3
 
 
 
 and 5
 
 
 
-TGCTCAGAAACTGC-
CAGGTCTG-3
 
 
 
; and 
 
 
 
-actin, 5
 
 
 
-GTGGGGCGCCCCAGGCACCA-
3
 
 
 
 and 5
 
 
 
-CTCCTTAATGTCACGCACGATTTC-3
 
 
 
. Total RNA was
extracted by using TRIzol reagent (GIBCO BRL), according to
the manufacturer’s procedure. 1 
 
 
 
g of RNA was reverse tran-
scribed using Moloney murine leukemia virus reverse tran-
scriptase (GIBCO BRL). The cDNA was denatured for 5 min at
94
 
 
 
C, followed by 28 PCR cycles. Each cycle included a 1-min de-
naturation at 94
 
 
 
C, a 1-min primer annealing at 55
 
 
 
C, and a
2-min polymerization at 72
 
 
 
C. Each RT-PCR reaction mixture was
analyzed by electrophoresis on a 2% agarose gel and stained with
ethidium bromide.
 
Western Blot Analysis
 
RPE cells were lysed with lysing buffer containing 50 mM HEPES
(pH 7.4), 1% Triton X-100, 0.15 M sodium chloride, 10% glyc-
erol, 1.5 mM magnesium chloride, 1 mM EDTA, 1 mM sodium
orthovanadate, 10 mM sodium pyrophosphate, 1 mM AEBSF, 10
mM sodium ﬂuoride, 10 
 
 
 
g/ml aprotinin, and 10 
 
 
 
g/ml leupep-
tin. Lysates were incubated on ice for 15 min with shaking. The
extracts were then centrifuged at 15,000 rpm for 15 min at 4
 
 
 
C.
Western blot analyses of RPE cellular extracts followed the
manufacturer’s procedure. In brief, samples containing 20 
 
 
 
g of
protein were separated by SDS-PAGE and then electrotrans-
ferred to nitrocellulose membranes. For protein detection, sam-
ples were blocked with a solution of Tris-buffered saline contain-
ing 5% dry milk and 0.1% Tween-20 (TBST) at room tempera-
ture for 1 h, probed with anti-TLR4 mAb, and washed three
times in TBST. The membranes were incubated with horseradish
peroxidase–conjugated secondary antibody for 1 h at room tem-
perature and washed three times with TBST. The membranes
were then visualized using an enhanced chemiluminesence
technique.
 
Immunoﬂuorescence Staining
 
RPE cells were grown on glass coverslips to form subconﬂuent or
conﬂuent cultures. Samples were labeled using direct immuno-
ﬂuorescence. Cells were labeled with 80 ng/ml anti-TLR4 clone
HTA1216 for 20 min at 37
 
 
 
C followed by four rinses with HBSS.
In experiments using anti-TLR4 clone HTA125 for blocking,
cells were ﬁrst labeled with anti-TLR4 clone HTA1216 at 80 ng/
ml. Cells were also labeled with anti-CD36 mAb at 50 ng/ml for
20 min at 37
 
 
 
C followed by extensive washing with HBSS at room
temperature.
 
Fluorescence Microscopy
 
Cells were observed using an Axiovert ﬂuorescence microscope
(Carl Zeiss MicroImaging, Inc.) with mercury illumination inter-
faced to a computer using Scion image processing software
(Kindzelskii et al., 1998). A narrow bandpass discriminating ﬁlter
set (Omega Optical) was used with excitation at 485/22 nm and
emission at 530/30 nm for FITC, and an excitation of 540/20 nm
and emission at 590/30 nm for TRITC. Long-pass dichroic mir-
rors of 510 and 560 nm were used for FITC and TRITC, respec-
tively. For resonance energy transfer (RET) imaging, a 485/22
nm narrow bandpass discriminating ﬁlter for excitation, and a
590/30 nm ﬁlter was used for emission (Kindzelskii et al., 1997).
The ﬂuorescence images were collected with a Peltier-cooled in-
tensiﬁed charge-coupled device camera (Princeton Inst.).
Quantitative microﬂuorometry was used to evaluate RET lev-
els. This was performed using a cooled high-sensitivity photomul-
tiplier tube in a D104 detection system (Photon Technology In-
ternational, Inc.) attached to a Carl Zeiss MicroImaging, Inc. mi-
croscope (Kindzelskii et al., 2002; Olsen et al., 2003; Petty, 2003).
 
Detection of NAD(P)H Oscillations and Calcium Spikes
 
NAD(P)H autoﬂuorescence oscillations were detected as previ-
ously described (Kindzelskii et al., 2002; Olsen et al., 2003; Petty,
2003). To detect calcium signals, the calcium reporter indo-1 was
used as previously described (Kindzelskii and Petty, 2003). An iris
diaphragm was adjusted to exclude light from neighboring cells.
For detection of NAD(P)H and indo-1 ﬂuorescence, kinetic stud- 
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ies were performed using the quantitative microﬂuorometry ap-
paratus described in the preceding paragraph. Data were ana-
lyzed using Felix software (Photon Tech. Intl.).
 
Reactive Oxygen Metabolites
 
Pericellular reactive oxygen metabolite (ROM) release from sin-
gle cells was monitored as previously described (Kindzelskii et al.,
1998, 2002). In brief, cells were surrounded in 2% gelatin
containing 100 ng/ml dihydrotetramethylrosamine (H
 
2
 
TMRos)
(Molecular Probes). ROMs, especially H
 
2
 
O
 
2
 
, released by the cells
entered the gelatin matrix, where they oxidized H
 
2
 
TMRos to tet-
ramethylrosamine (TMRos), which was detected by ﬂuorescence
microscopy.
 
Statistics
 
Comparisons between groups were performed using Student’s 
 
t
 
test. Data are expressed as mean 
 
  
 
SEM. 
 
n
 
 is the number of sepa-
rate experiments performed. All experiments were repeated on
at least three independent occasions each consisting of 20–50
separate cellular measurements. All experiments used at least
three different RPE donors.
 
RESULTS
 
RPE Cells Express TLR4
 
We ﬁrst tested the hypothesis that RPE cells express
TLR4. TLR4 message was demonstrated in RPE cells
following RNA extraction and RT-PCR, as shown in the
top panel of Fig. 1. To demonstrate that this message
yielded an antigenically intact protein, RPE cells were
solubilized in Triton X-100/HEPES buffer followed by
SDS-PAGE. When nitrocellulose blots were probed with
anti-TLR4, protein expression was conﬁrmed (Fig. 1,
bottom). To demonstrate that TLR4 was expressed on
the cell surface, living RPE cells were stained with ﬂuo-
rescein-conjugated anti-TLR4 mAb. Direct immunoﬂu-
orescence microscopy demonstrated that anti-TLR4
mAb (Fig. 2, C and G, and Fig. 3, C, G, and K), but not
isotype-matched controls (not depicted), labeled RPE
cells. Therefore, the TLR4 gene is expressed by
RPE cells, and the protein product trafﬁcs to the cell
surface.
 
TLR4 Clustering Accompanies POS Binding to RPE Cells, 
But Is Blocked by an Inhibitory Anti-TLR4 mAb
 
TLRs elicit transmembrane signals that participate in
the clearance of pathogens and endogenous molecules
by several cell types. Therefore, we tested the hypothesis
that TLR4 participates in POS binding and/or signaling
on RPE cells. Human RPE cells were grown until they
formed a conﬂuent monolayer on glass coverslips. Cell
surface TLR4 molecules were trace labeled using a sub-
saturating dose (80 ng/ml) of rhodamine-conjugated
Figure 1. Expression of TLR4 by human RPE cells. (A) RT-PRC
demonstrates the presence of TLR4 message. (B) Western blots
demonstrate the presence of TLR4 antigen in RPE cells.
Figure 2. TLR4 clusters at the sites of POS binding. Representative DIC (A and E), ﬂuorescence (B, C and F, G), and RET (D and H)
micrographs are shown. RPE cells were trace labeled with TRITC-conjugated anti-TLR4 (clone HTA1216) at 80 ng/ml and then incubated
for 2 h at 37 C. In panels E–H, cells were trace labeled using anti-TLR4 clone HTA1216 and then incubated with anti-TLR4 clone HTA125
at 30  g/ml for 2 h at 37 C to block TLR4. RPE cells were then incubated with FITC-conjugated human POS, which were found to
randomly label the surface of RPE cells (B and F). In the absence of anti-TLR4 clone HTA125, TLR4 clustered at sites of POS binding (C),
and the anti-TLR4 clone HTA1216 mAb was found in close proximity with the POS (D). However, incubation with a saturating dose of the
anti-TLR4 clone HTA125 blocked clustering of the anti-TLR4 clone HTA1216 (G) and RET with POS (H) ( 375) (n   3). 
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anti-TLR4 mAb (clone HTA1216) at 37
 
 
 
C. Human POS
were FITC-labeled as previously described (McLaren et
al., 1993). FITC-conjugated POS were incubated for 20
min with RPE cells that were previously cultured on ster-
ile microscope coverslips, gently washed, and then ob-
served microscopically at 37
 
 
 
C. The concentration of
POS was adjusted to give signiﬁcant binding without ob-
scuring other cellular details, which corresponded to a
POS/cell ratio of 10:1. Fig. 2 B shows a low magniﬁca-
tion micrograph illustrating the punctate POS labeling
of an RPE monolayer. The ﬂuorescent anti-TLR4 mAb
was found to cluster near sites of POS binding (Fig. 2
C). To further establish this observation, RET micros-
copy was performed. As illustrated in Fig. 2 D, RET was
observed between the FITC-labeled POS and TRITC-
labeled anti-TLR4 reagent, indicating that these mole-
cules are in close physical proximity.
To ascertain if functional TLR4 is important in TLR4
clustering on RPE surfaces, we employed a saturating
dose of an inhibitory anti-TLR4 mAb (clone HTA125;
Akashi et al., 2000; Tabeta et al., 2000). Cells were
ﬁrst labeled with a subsaturating dose (80 ng/ml) of
rhodamine-conjugated anti-TLR4 mAb (clone HTA1216),
as described above. This was followed by incubation
Figure 3. TLR4 accumulates at sites of human but not bovine POS on human RPE cells. Representative DIC (column 1), ﬂuorescence
(columns 2 and 3), and RET (column 4) micrographs are shown. RPE cells were labeled with TRITC-conjugated anti-TLR4 (clone
HTA1216). Human RPE cells were incubated with FITC-conjugated human POS (A–D), no POS (E–H), or FITC-conjugated bovine POS
(I–L). In the absence of POS, TLR4 was uniformly distributed on RPE cells (G). Human POS bound to human RPE cells (B), which was
accompanied by the coclustering of TLR4 (C). When RET was examined, RET was observed between the surface of the POS and TLR4
(D). When ﬂuorescent bovine POS were incubated with human RPE cells, no coclustering with TLR4 could be detected. Thus, in contrast
to the results found in Fig. 4 for CD36, only human POS promote the coclustering of TLR4 (n   9) ( 736).
 
TABLE I
 
Quantitative Comparison of RET Intensities Using Various Experimental Conditions
 
Donor Acceptor Nature of RET Measurement (counts/s)
POS type TLR4 Individual POS Single Cell Monolayer Region
None
 
 
 
n/a 0.1 
 
 
 
 0.1 
 
 
 
 10
 
5
 
0.15 
 
 
 
 0.15 
 
 
 
 10
 
5
 
Human
 
 
 
0.3 
 
 
 
 0.2 
 
 
 
 10
 
4
 
0.11 
 
 
 
 0.08 
 
 
 
 10
 
5
 
0.25 
 
 
 
 0.1 
 
 
 
 10
 
5
 
Human
 
 
 
9.2 
 
 
 
 1.7 
 
 
 
 10
 
4
 
1.6 
 
 
 
 2.4 
 
 
 
 10
 
5
 
1.9 
 
 
 
 0.5 
 
 
 
 10
 
5
 
Bovine
 
 
 
0.4 
 
 
 
 0.3 
 
 
 
 10
 
4
 
0.13 
 
 
 
 0.1 
 
 
 
 10
 
5
 
0.22 
 
 
 
 0.15 
 
 
 
 10
 
5
 
Background 3.2 
 
 
 
 0.6 
 
 
 
 10
 
3
 
0.8 
 
 
 
 0.1 
 
 
 
 10
 
4
 
1.2 
 
 
 
 0.2 
 
 
 
 10
 
4
 
The value of 
 
n
 
 is 3–5 for these experiments. Columns three through five show quantitative measurements of RET intensities made on individual POS in a
region of interest, a single RPE cell from a subconfluent monolayer, and a defined region of a confluent monolayer approximating one cell in size. For
each experiment, 20–50 cells were measured. The background count rate was measured on an irrelevant part of a labeled slide. The background count
rate was subtracted from the measurements shown. The human POS RET levels were significantly greater than those elicited by bovine POS using all three
measurement methods (P 
 
 
 
 0.01). 
143
 
Kindzelskii et al.
 
with a saturating dose (30 
 
 
 
g/ml) of anti-TLR4 mAb
clone HTA125 for 2 h at 37
 
 C, followed by washing
with medium. FITC-conjugated POS were added to
cells and then observed microscopically at 37 C. Al-
though POS bound to cells treated with a saturating
dose of HTA125 (Fig. 2 F), TLR4 clustering at POS was
not observed (Fig. 2 G) and RET between TLR4 and
POS was not detected (Fig. 2 H). To control for poten-
tial nonspeciﬁc effects of mAb treatment, cells were la-
beled with anti-TLR4 mAb (clone HTA1216), as de-
scribed above, followed by 30  g/ml of an isotype-
matched control mAb. Under these conditions, TLR4
clustered as previously described in the absence of
saturating anti-TLR4 treatment (unpublished data).
Thus, saturating doses of an inhibitory antibody were
found to block the clustering of TLR4 in response to
POS binding.
Subconﬂuent RPE cultures were also used as they
were more readily labeled with mAb reagents and facil-
itated receptor analysis on individual cells. Fluores-
cently labeled POS were incubated with RPE cells as de-
scribed in the preceding paragraph. Cells were labeled
with TRITC-conjugated anti-TLR4 mAb. Fig. 3 G shows
that TLR4 is uniformly distributed on untreated RPE
cells. When human POS bind to RPE cells, TLR4 clus-
ters at the site of POS binding (Fig. 3, A–C). However,
when bovine POS bind to human RPE cells, TLR4 is
unaffected (Fig. 3, I–L). Moreover, human POS, but
not bovine POS, induce physical proximity between
TLR4 and POS (Fig. 3, D vs. L). Quantitative RET data
are shown in Table I for these measurements as well as
controls that omitted separately each ﬂuorescent label.
Table I also shows a parallel series of RET experiments
performed on conﬂuent cell monolayers. Thus, POS
and TLR4 cocluster at the surface of sub-conﬂuent RPE
cells. Therefore, human, but not bovine, POS induce
clustering of TLR4 at their binding sites. This suggests
an important difference between the homologous and
heterologous cell systems.
Clustering of TLR4 and CD36 at Sites of Outer Segment 
Binding: Differential Effects of Human and Bovine POS
Previous studies have reported that CD36 participates
in the clearance of POS by RPE cells (Finnemann and
Silverstein, 2001). In other systems, different mem-
brane receptors collect at the site of phagocytosis (e.g.,
Petty et al., 1989). We therefore examined the cell sur-
face distribution of CD36 on RPE cells in response to
POS binding. On untreated cells, CD36 was predomi-
nantly found to be randomly distributed on RPE mem-
branes (Fig. 4 C). Both human and bovine POS bound
to human RPE cells, as conﬁrmed microscopically (Fig.
4, F and J). Cells were also labeled with TRITC-conju-
gated anti-CD36. Sites of POS binding corresponded to
sites of CD36 accumulation (Fig. 4, G and K), although
some of the CD36 ﬂuorescence remained uniformly
distributed. Furthermore, the presence of RET between
the POS and CD36 molecules suggests that the POS are
Figure 4. Human and bovine
POS promote CD36 clustering
on human RPE cells. Representa-
tive DIC (column 1), ﬂuores-
cence (columns 2 and 3), and
RET emission (column 4) micro-
graphs are shown. RPE cells were
labeled with TRITC-conjugated
anti-CD36. Samples were then
incubated in the absence of POS
(A–D), FITC-conjugated human
POS (E–H), or FITC-conjugated
bovine POS (I–L). In the absence
of POS, CD36 was distributed
about the perimeter of RPE cells
(C). Human POS bound to hu-
man RPE cells (F), which was
accompanied by the coclustering
of CD36 (G). When RET was
evaluated, RET was observed
between the surface of the POS
and CD36 (H). When ﬂuores-
cent bovine POS were incubated
with human RPE cells, a similar
set of observations were made
(I–L). Thus, both human and
bovine POS promote the coclus-
tering of CD36 in their vicinity
(n   8) ( 736).144 Toll-like Receptor 4 of RPE Cells
in close physical proximity with CD36 (Fig. 4, H and
L). Using quantitative microﬂuorometry, POS-to-CD36
RET intensities for whole cells of 1.6   0.4   105 and
1.7   0.5   105 counts per second were obtained for
human and bovine POS, respectively, in comparison to
controls omitting POS (0.1   0.1   105 counts per sec-
ond). Therefore, human and bovine POS induce clus-
tering of CD36 at their binding sites, thus supporting
the potential role of CD36 in handling POS.
A parallel series of experiments were performed us-
ing FITC-labeled anti-CD36 and TRITC-labeled anti-
TLR4. RET microscopy indicated that CD36 and TLR4
were in close physical proximity on RPE cells at sites of
POS binding (Fig. 5 H), as might be expected. How-
ever, RET was also observed on untreated RPE cells, in-
dicating the molecular proximity of these molecules
(Fig. 5 D). These RET ﬁndings for CD36-to-TLR4 prox-
imity in the absence and presence of POS were con-
ﬁrmed using quantitative microﬂuorometry of separate
whole cells (1.8   0.5   105 vs. 1.9   0.3   105 counts
per second, respectively). Thus, the level of RET is in-
distinguishable in the presence and absence of recep-
tor clustering due to POS. This observation suggests
that TLR4 and CD36 may be components of the same
supramolecular complex on RPE cell membranes. The
substantial reduction in RET intensity on cells incu-
bated with bovine POS is likely due to the redistribu-
tion of CD36 to the POS and the lack of TLR4 accumu-
lation at these sites.
Arrival of TLR4 at Sites of Human POS Binding Coincides 
with Metabolic and Calcium Signaling Events
To examine the potential role of RPE TLR4 in POS sig-
naling events, we performed simultaneous kinetic stud-
ies of receptor accumulation at POS binding sites and
intracellular metabolic and calcium signaling processes.
Cells were labeled with FITC-anti-CD36, TRITC-anti-
TLR4, and/or the calcium-sensitive probe indo-1AM.
The ﬂuorescence intensities of the CD36, TLR4, or the
RET between these two labels was measured within a
circular region including and surrounding individual
bound POS, which was selected using region-of-interest
software. Kinetic changes in the ﬂuorescence intensity
in the region-of-interest were recorded immediately af-
ter POS addition to the RPE cells. Although the total
ﬂuorescence intensity of the cell does not change (un-
published data), the ﬂuorescence intensity surround-
ing the POS does change. Fig. 6 A shows representative
kinetic studies of CD36 and TLR4 accumulation at a
POS. The curves appear as dashed lines because the ﬁl-
ter and dichroic mirror set was moved between the two
positions to detect these two ﬂuorochromes during
data acquisition. Fig. 6 A shows that CD36 arrives at the
sites of POS binding before TLR4, with an approximate
lag time of 2–2.5 min. The RET signal between the
CD36 and TLR4 labels initially falls (not depicted); this
is followed by a subsequent increase in RET in the vi-
cinity of the POS (Fig. 6, B and C), as anticipated by
Fig. 5 H. When RET emission and NAD(P)H autoﬂuo-
Figure 5. Human POS pro-
mote coclustering of CD36 and
TLR4 on human RPE cells.
Representative DIC (column 1),
ﬂuorescence (columns 2 and 3),
and RET (column 4) micro-
graphs are shown. RPE cells were
labeled with TRITC-conjugated
anti-CD36 and FITC-conjugated
anti-TLR4. Samples were then
incubated with human or bovine
POS. CD36 and TLR4 were dis-
tributed about the perimeter of
RPE cells (B and C). In the pres-
ence of human POS, CD36 (F)
and TLR4 (G) coclustered on
human RPE cells. RET micros-
copy demonstrated low levels of
energy transfer on untreated
cells (D). However, bright areas
of RET could be observed on
RPE cells in the presence of
human POS (H). In contrast,
bovine POS did not induce co-
clustering of CD36 and TLR4 or
RET between these labels (J–L).
Thus, human POS promote the
coclustering of CD36 and TLR4
(n   6) ( 736).145 Kindzelskii et al.
rescence were simultaneously recorded, high frequency
NAD(P)H oscillations were detected after CD36 and
TLR4 came into close proximity on RPE cells (Fig. 6
B). Similarly, calcium spikes, as judged by the increased
emission of indo-1, are observed in RPE cells, but only
after the formation of proximity complexes of CD36
and TLR4 (Fig. 6 D) at POS binding sites. Thus, TLR4
appears to be one component necessary for the initia-
tion of metabolic and calcium signaling in response to
human POS binding.
Apparent Role of TLR4 Clustering in RPE Signaling in 
Response to POS
If TLR4 clustering is required for certain elements of
POS signaling within RPE cells, then bovine POS
should not be capable of eliciting these changes. To
test this hypothesis, bovine POS were incubated with
human RPE cells. Bovine POS were unable to induce
NAD(P)H oscillations or calcium spikes in RPE cells
(Fig. 7, a and b). RPE cells were also incubated with hu-
man POS. In this case, however, both NAD(P)H oscilla-
tions and calcium spikes were observed (Fig. 7, e and
f). Furthermore, NAD(P)H oscillations and calcium
spikes were observed on conﬂuent human RPE mono-
layers in regions with bound human POS (Fig. 8). The
metabolic oscillations and calcium signals in cell mono-
layers were substantially greater in amplitude than
those of single cells, which may be due to the fact that
multiple cells (approximately three to ﬁve) are illumi-
nated during these observations on monolayers. These
ﬁndings are consistent with the proposed role of TLR4
in these two elements of RPE cell signaling in response
to human POS.
The experiments shown in Fig. 2 demonstrate that an
inhibitory anti-TLR4 mAb blocks TLR4 clustering in re-
sponse to human POS. Therefore, we tested the ability
of this reagent to effect metabolic and calcium signal-
ing. When cells were treated with anti-TLR4 clone
HTA1216 at 80 ng/ml, no effect on metabolic oscilla-
tions and calcium signaling in response to human POS
was noted (Fig. 7, i and j). However, when RPE cells
were exposed to anti-TLR4 clone HTA1216 at 80 ng/
Figure 6. Quantitative kinetic analysis of receptor complex
assembly and signaling at sites of POS binding. Using a PMT
detector, photon count rates in the vicinity of bound POS were
measured. Intensity is plotted at the ordinate, whereas time is
given at the abscissa. The region surrounding the POS was selected
by an iris in a back focal plane of the microscope. (A) Samples
were labeled with both TRITC-conjugated anti-CD36 and FITC-
conjugated anti-TLR4. The kinetics of CD36 and TLR4 accumula-
tion at the site of POS binding is shown. CD36 arrives at the site of
POS binding before TLR4. (B) Correspondence between the
times of anti-CD36-to-anti-TLR4 RET and the exhibition of
NAD(P)H oscillations during POS binding. (C) Kinetics of RET
acquisition between anti-CD36 and anti-TLR4 at a site of POS
binding. (D) Cells were labeled with anti-CD36 and anti-TLR4 and
with the calcium indicator indo-1. Correspondence between the
times of anti-CD36-to-anti-TLR4 RET and the initiation of calcium
spikes in RPE cells (n   4).
Figure 7. Representative NAD(P)H oscil-
lations and oxidant release proﬁles of RPE
cells. Human RPE cells were incubated
with bovine (a–d) or human (e–p) POS.
Cells were monitored for NAD(P)H con-
centration (a, e, i, and m), intracellular
calcium levels (b, f, j, and n), oxidant re-
lease (c, g, k, and o), and oxidant release
in the presence of superoxide dismutase
(SOD) (d, h, l, and p). Although bovine
POS did not affect NAD(P)H and calcium
signals of human RPE cells (a and b), these
signals were apparent when cells were incu-
bated with human POS (e and f). The
release of oxidants was detected with H2-
TMRose as previously described (Kindzelskii et al., 1998). In parallel with their effects on signaling, bovine POS did not induce oxidant
release (c), whereas human POS promoted oxidant release (g). This oxidant release could be inhibited by SOD (h). The ability of POS to
stimulate metabolic oscillations, calcium signaling, and ROM release was not affected by prior labeling with anti-TLR4 (clone HTA1216;
80 ng/ml) (i–l). However, labeling with anti-TLR4 clone HTA1216 followed with treatment with anti-TLR4 clone HTA125 at 30  g/ml
blocked metabolic oscillations, calcium signaling, and ROM release (m–o) (n   5). Bar, 30 s.146 Toll-like Receptor 4 of RPE Cells
ml, washed, and then incubated with 30  g/ml anti-
TLR4 clone HTA125 for 20 min, metabolic oscillations
and calcium signaling in response to human POS were
inhibited (Fig. 7, m and n). Thus, several lines of evi-
dence support the idea that TLR4 accumulation at sites
of POS binding participate in RPE responses for the
homologous human POS/human RPE cell system.
Human, but Not Bovine, POS Promote the Production of 
ROM by Human RPE Cells, Which Can Be Blocked by an 
Inhibitory Anti-TLR4 mAb
Inasmuch as TLRs participate in host defense by leuko-
cytes (Akira, 2000; Schuster and Nelson, 2000; Dobro-
volskaia and Vogel, 2002), RPE cells have been re-
ported to produce superoxide anions (Dorey et al.,
1989; Miceli et al., 1994; Tate et al., 1995; Wu and Rao,
1999), and metabolic oscillations and calcium signaling
have been correlated with ROM production (Petty,
2001), we tested the hypothesis that POS promote
ROM release. ROM production by RPE cells was mea-
sured as previously described (Kindzelskii et al., 1998).
Human RPE cells that were untreated (not depicted)
or treated with bovine POS (Fig. 7 c) did not produce
ROM that could be detected by this assay. However, hu-
man POS did stimulate ROM production by human
RPE cells (Fig. 7 g), which could be inhibited by the
ROM scavenger superoxide dismutase (SOD) (Fig. 7 h).
To reconﬁrm the functional role of TLR4 in this re-
sponse to human POS, cells were treated with anti-
TLR4 mAbs. When cells were treated with anti-TLR4
clone HTA1216, ROM production in response to hu-
man POS was noted, as in the absence of this reagent.
However, when RPE cells were exposed to anti-TLR4
clone HTA1216 at 80 ng/ml, washed, and then incu-
bated with 30  g/ml anti-TLR4 clone HTA125 for 20
min, ROM production in response to human POS was
blocked (Fig. 7 o), which could not be distinguished
from negative controls (Fig. 7 p). Thus, this physiologi-
cal response to human POS is apparently tied to TLR4
function and transmembrane signaling, which is likely
important in the management of POS by RPE cells.
DISCUSSION
Although human TLRs were discovered only a few
years ago, they have come to occupy center stage in
innate immunity against invading pathogens (Akira,
2000; Schuster and Nelson, 2000; Dobrovolskaia and
Vogel, 2002). The breadth of the importance of TLR
genes in humans is not yet known, but given the heter-
ogeneity of Toll functions found in Drosophila as well as
the broad functions of other pattern recognition recep-
tors, the TLR proteins are likely to occupy several key
biological roles. Speciﬁcally, human TLR4 participates
in cellular responses to the exogenous substances LPS
of Gram-negative bacteria, lipoteichoic acid of Gram-
positive bacteria, and the F protein of respiratory syncy-
tial virus and as a receptor for the endogenous sub-
stances HSP60 (and certain homologous proteins), the
ﬁbronectin extra domain A, and hyaluronan (Barton
and Medzhitov, 2002; Beg, 2002; Johnson et al., 2003).
In a preliminary report, we previously noted that TLR4
is present on RPE cells (Petty et al., 2003). The present
study extends the repertoire of TLRs to potentially in-
clude vision-related processes of RPE cells. Our work
suggests that TLR4 of human RPE cells participates in
the cellular handling of human POS on both conﬂuent
Figure 8. Representative NAD(P)H oscillations and calcium spikes of RPE cells. The intensity is plotted at the ordinate, whereas
the time in seconds is given at the abscissa. Experiments were performed as described in the preceding ﬁgure. Human RPE cells were
incubated with human POS followed by analyses of NAD(P)H oscillations (A and C) or calcium spikes (B and D). Single cells (A and B)
and cell layers (C and D) were evaluated. In the case of cell layers, more than one cell was illuminated, thereby leading to the higher
amplitudes of the oscillations. Nonetheless, similar behaviors were noted for single cells and monolayers.147 Kindzelskii et al.
cultures, which resemble normal physiological condi-
tions, and subconﬂuent cultures, which resemble the
migratory RPE cells associated with certain disease pro-
cesses (Hogg et al., 2002). Several lines of experimental
evidence now support a possible role of TLR4 in RPE
responses to POS. These include (a) TLR4 clusters on
human RPE surfaces in response to human POS, but
not bovine POS, (b) TLR4 arrives at human POS just
before signal transduction, and (c) an inhibitory anti-
TLR4 mAb blocks TLR4 clustering, calcium signaling,
and metabolic responses of RPE cells to human POS.
Several steps are involved in the RPE-mediated clear-
ance of POS. These include binding to the RPE sur-
face, phagocytosis, and lysosomal destruction. Although
binding of POS to RPE cells occurs rapidly ( 1 h),
phagocytosis requires roughly 3 h (Hall and Abrams,
1987). As all of the above observations were made less
than 1 h. after POS addition, they are relevant to the
early events during POS-to-RPE cell interactions. One
fundamental requirement of transmembrane signaling
is that the receptor is engaged before or during the
production of a transmembrane signal. Our experi-
ments show that calcium and metabolic changes are
preceded by CD36 and TLR4 accumulation at sites of
POS binding. These ﬁndings are consistent with a pos-
sible role of these molecules in signaling in response
to POS.
Several RPE membrane proteins may participate in
the clearance of POS. The membrane protein MERTK
plays a central role in generating signals leading to POS
phagocytosis (Feng et al., 2002). The role of MERTK in
eye disease has been further established by genetic
studies (Gal et al., 2000; D’Cruz et al., 2000). Evidence
has suggested that the membrane proteins CD36 and
 V 5 participate in POS binding to RPE cells (Finne-
mann et al., 1997; Finnemann and Silverstein, 2001).
The role of CD36 in recognition is not surprising since
this is a pattern recognition receptor of broad speciﬁc-
ity (Febbraio et al., 2001). However, the fact that RET
was detected between CD36 and TLR4 was surprising;
this suggests that they may cluster in the same cell
membrane domain or are physically associated with
one another. In either case, it will be interesting to de-
termine if CD36 and TLR4 have cooperative roles in
other biological systems. Our data suggest that TLR4
may participate in the clearance of POS, such as the
stimulation of additional RPE signaling pathways neces-
sary for the degradation of POS. Therefore, we specu-
late that POS clearance is managed by a supramolecu-
lar complex of membrane proteins. This may be analo-
gous to the handling of LPS by leukocytes, which
involves multiple membrane-associated proteins, in-
cluding CD14, TLR4, MD-2, and  -2 integrins; several
of these proteins are already known to interact with
one another in cell membranes (Petty et al., 2002). In
this system, CD14, TLR4, and  -2 integrins are thought
to be primarily, but not exclusively, responsible for LPS
binding, signaling for cytokine up-regulation, and
phagocytic uptake, respectively. Similarly, the POS clear-
ance may involve CD36 as a participatory recognition
molecule, MERTK as a phagocytosis signaling mole-
cule, and TLR4 as an activating stimulus, which is spe-
ciﬁc for a molecular pattern on human POS. Although
integrin  V 5 may not participate directly in phagocyto-
sis (Hall et al., 2003), it may participate in other aspects
of POS management, such as facilitating and integrat-
ing signal transduction, as in the leukocyte system (Vo-
gel et al., 2001).
Although we suggest that POS are managed by a su-
pramolecular assembly of membrane components, this
complex may not be static. For example, our studies
have also shown that CD36 arrives at POS before TLR4.
This ﬁnding suggests that CD36 plays an earlier role
managing POS whereas TLR4 appears to play a down-
stream role including calcium and metabolic signaling
and ROM production. The apparent role of TLR4 in
calcium and metabolic signaling is also supported by
the fact that an inhibitory anti-TLR4 mAb blocks these
signals. Thus, RPE cell TLR4 molecules appear to be an
important contributor to certain aspects in the man-
agement of POS. Further analysis of proteins that may
contribute to POS clearance mechanisms, including
their supramolecular structures and their dynamic reg-
ulation, such as the timing of MERTK recruitment, as
well as their subsequent disassembly and recycling will
be future challenges in understanding this biological
pathway.
Recent studies have indicated that TLR4 of leuko-
cytes stimulates the cell functions, such as the produc-
tion of ROM (Hayashi et al., 2003; Werling et al., 2004).
Furthermore, analysis of mice genetically deﬁcient in
TLR4 indicates that TLR4 contributes to the induction
of ROM production in leukocytes (Remer et al., 2003).
Previous studies have indicated that RPE cells are capa-
ble of generating ROM under certain conditions
(Dorey et al., 1989; Miceli et al., 1994; Tate et al., 1995;
Wu and Rao, 1999). Therefore, it seems possible that
TLR4 clustering and transmembrane signaling contrib-
ute to ROM production. Our studies have shown that
RPE cells produce ROM in response to POS. Further-
more, an inhibitory anti-TLR4 mAb blocks ROM pro-
duction in response to POS. Our studies suggest that in
RPE cells, as in leukocytes, TLR4 can participate in
transmembrane signaling leading to ROM production.
Although RPE cells can produce ROM (Dorey et al.,
1989; Miceli et al., 1994; Tate et al., 1995; Wu and Rao,
1999), this process has not been studied in detail in the
RPE system. In the present study, we have observed sig-
niﬁcant rates of ROM generation, but only with the ho-
mologous human RPE–human POS system. Although a148 Toll-like Receptor 4 of RPE Cells
previous study noted ROM production in the heterolo-
gous system (Dorey et al., 1989), the rate of ROM pro-
duction was much lower than our observations in the
homologous system. Although our single cell assay did
not detect ROM production over several minutes for
the heterologous system, a previous study (Dorey et al.,
1989) of millions of cells detected ROM production
over a period of hours. Thus, our ﬁndings are consis-
tent with prior reports and indicate that the homolo-
gous system provides more robust results. Furthermore,
a signiﬁcant level of oxidant production is only ob-
served using human POS, which is accompanied by
TLR4 recruitment, calcium signaling, and metabolic
changes. As bovine POS do not elicit these responses, it
would appear that the heterologous bovine POS–
human RPE system is not a good model for certain as-
pects of POS clearance. Thus, results with heterologous
systems should be conﬁrmed using more physiological
homologous systems. In the present study, the bovine
POS–human RPE system served as a negative control.
We believe that prior studies using heterologous sys-
tems necessarily missed the involvement of TLRs in
POS handling and downstream RPE functions such as
ROM production. Human POS have the ability to in-
duce metabolic changes, calcium signals, and ROM
production in human RPE cells, which are characteris-
tics of immunologically primed neutrophils (Petty,
2001). We speculate that TLR4 clustering may also play
important roles in proinﬂammatory pathophysiologic
changes in the eye that accompany retinal diseases
such as uveitis, age-related macular degeneration, and
proliferative vitreoretinopathy. From a more general
perspective, our studies on TLR4, transmembrane sig-
naling, and oxidant release lead to the speculation that
POS binding creates a local proinﬂammatory environ-
ment in the eye, which might be triggered to form
a “full-blown,” damaging inﬂammatory response by
small perturbations (cytokines, LPS, etc.) in the local
environment.
Recent animal experiments are consistent with the
potential role of TLR4 and proinﬂammatory condi-
tions as modulators of eye disease. The mnd (motor
neuron degeneration) mouse, which displays retinal
disease at 1 mo of age accompanied by more general
neurologic aberrations at 6 mo (Messer et al., 1995), is
a good model of neuronal ceroid lipofuscinosis (Batten
disease) (Chang et al., 1994). It has been shown
that  when C57BL/6.KB2-mnd mice are out-crossed
with AKR/J mice (TLR4 positive), the disease becomes
more aggressive, whereas out-crossing with the C3H/
HeJ background (TLR4 defective) has no effect on the
timing of disease (Messer et al., 1999; Bihl et al., 2001).
Recently, C57BL/6.KB2-mnd mice have been shown to
possess a novel mutation in TLR4 leading to hypore-
sponsiveness to LPS (Bihl et al., 2001). Thus, the lack
of functional TLR4 appears to have a protective in-
ﬂuence in these animals. The TLR4-mediated signals
noted above may contribute to the accelerated retinal
degeneration of TLR4-positive animals. Thus, the pro-
inﬂammatory conditions found during POS turnover
may constitute a previously unsuspected modulator of
disease aggressiveness acting through the TLR4 path-
way outlined above. Recent studies have associated
TLR4 polymorphisms with the risk of atherogenesis
(Kiechl et al., 2003), which may have an important in-
ﬂammatory component. These ﬁndings in animals and
humans and our present in vitro studies raise the pos-
sibility that TLR4 polymorphisms in humans may
contribute to the severity of eye disease, especially
ROM-related eye diseases such as age-related macular
degeneration.
This research was supported by the National Institutes of Health
grants AI51789 (H.R. Petty), EY09441 (V.M. Elner), EY08850 (B.
Hughes), and EY07003 (core). V.M. Elner and B. Hughes are re-
cipients of Research to Prevent Blindness Wasserman grants.
Olaf S. Andersen served as editor.
Submitted: 12 March 2004
Accepted: 17 June 2004
REFERENCES
Akashi, S., H. Ogata, F. Kirikae, T. Kirikae, K. Kawasaki, M. Nish-
ijima, R. Shimazu, Y. Nagai, K. Fukudome, M. Kimoto, and K.
Miyake. 2000. Regulatory roles for CD14 and phosphatidylinosi-
tol in the signaling via toll-like receptor 4-MD-2. Biochem. Biophys.
Res. Commun. 268:172–177.
Akira, S. 2000. Toll-like receptors: lessons from knockout mice. Bio-
chem. Soc. Trans. 28:551–556.
Barton, G.M., and R. Medzhitov. 2002. Toll-like receptors and their
ligands. Curr. Top. Microbiol. Immunol. 270:81–92.
Beg, A.A. 2002. Endogenous ligands of Toll-like receptors: implica-
tions for regulating inﬂammatory and immune responses. Trends
Immunol. 23:509–512.
Bihl, F., L. Lariviere, S.T. Qureshi, L. Flaherty, and D. Malo. 2001.
LPS-hyporesponsiveness of mnd mice is associated with a muta-
tion in Toll-like receptor 4. Genes Immun. 2:56–59.
Chang, B., R.T. Bronson, N.L. Hawes, T.H. Roderick, C. Peng, G.S.
Hageman, and J.R. Heckenlively. 1994. Retinal degeneration in
motor neuron degeneration: a mouse model of ceroid lipofusci-
nosis. Invest. Ophthalmol. Vis. Sci. 35:1071–1076.
D’Cruz, P.M., D. Yasumura, J. Weir, M.T. Matthes, H. Abderrahim,
M.W. LaVail, and D. Vollrath. 2000. Mutation of the receptor ty-
rosine kinase gene Mertk in the retinal dystrophic RCS rat. Hum.
Mol. Genet. 9:645–651.
Dorey, C.K., G.G. Khouri, L.A. Syniuta, S.A. Curran, and J.J. Weiter.
1989. Superoxide production by porcine retinal pigment epithe-
lium in vitro. Invest. Ophthalmol. Vis. Sci. 30:1047–1054.
Dobrovolskaia, M.A., and S.N. Vogel. 2002. Toll receptors, CD14,
and macrophage activation and deactivation by LPS. Microbes In-
fect. 4:903–914.
Elner, V.M., R.M. Streiter, V.M. Elner, B.J. Rollins, M.A. Del Monte,
and S.L. Kunkel. 1991. Monocyte chemotactic protein gene ex-
pression by cytokine-treated human retinal pigment epithelial
cells. Lab. Invest. 64:819–825.
Febbraio, M., D.P. Hajjar, and R.L. Silverstein. 2001. CD36: a class B
scavenger receptor involved in angiogenesis, atherosclerosis, in-149 Kindzelskii et al.
ﬂammation, and lipid metabolism. J. Clin. Invest. 108:785–791.
Feng, W., D. Yasumura, M.T. Matthes, M.M. LaVail, and D. Vollrath.
2002. Mertk triggers uptake of photoreceptor outer segments
during phagocytosis by cultured retinal pigment epithelial cells.
J. Biol. Chem. 277:17016–17022.
Finnemann, S.C., and R.L. Silverstein. 2001. Differential roles of
CD36 and  V 5 integrin in photoreceptor phagocytosis by retinal
pigment epithelium. J. Exp. Med. 194:1289–1298.
Finnemann, S.C., V.L. Bonilha, A.D. Marmorstein, and E. Rod-
riguez-Boulan. 1997. Phagocytosis of rod outer segments by reti-
nal pigment epithelial cells requires  V 5 integrin for binding
but not for internalization. Proc. Natl. Acad. Sci. USA. 94:12932–
12937.
Gal, A., Y. Li, D.A. Thompson, J. Weir, U. Orth, S.G. Jacobson, E.
Apfelstedt-Sylla, and D. Vollrath. 2000. Mutations in MERTK, the
human orthologue of the RCS rat retinal dystrophy gene, cause
retinitis pigmentosa. Nat. Genet. 26:270–271.
Hall, M.O., and T. Abrams. 1987. Kinetic studies of rod outer seg-
ment binding and ingestion by cultured rat RPE cells. Exp. Eye
Res. 45:907–922.
Hall, M.O., T.A. Abrams, and B.L. Burgess. 2003. Integrin alpha-
vbeta5 is not required for the phagocytosis of photoreceptor
outer segments by cultured retinal pigment epithelial cells. Exp.
Eye Res. 77:281–286.
Hayashi, F., T.K. Means, and A.D. Luster. 2003. Toll-like receptors
stimulate human neutrophil function. Blood. 102:2660–2669.
Hogg, P.A., I. Grierson, and P. Hiscott. 2002. Direct comparison of
the migration of three cell types involved in epiretinal mem-
brane formation. Invest. Ophthalmol. Vis. Sci. 43:2749–2757.
Hornef, M.W., T. Frisan, A. Vandewalle, S. Normark, and A. Rich-
ter-Dahlfors. 2002. Toll-like receptor 4 resides in the Golgi appa-
ratus and colocalizes with internalized lipopolysaccharide in in-
testinal epithelial cells. J. Exp. Med. 195:559–570.
Johnson, G.B., G.J. Brunn, and J.L. Platt. 2003. Activation of mam-
malian Toll-like receptors by endogenous agonists. Crit. Rev. Im-
munol. 23:15–44.
Kiechl, S., C.J. Wiedermann, and J. Willeit. 2003. Toll-like receptor
4 and atherogenesis. Ann. Med. 35:164–171.
Kindzelskii, A.L., and H.R. Petty. 2003. Intracellular calcium waves
accompany neutrophil polarization, fMet-Leu-Phe stimulation
and phagocytosis: a high-speed microscopy study. J. Immunol.
170:64–72.
Kindzelskii, A.L., M.M. Eszes, R.F. Todd III, and H.R. Petty. 1997.
Proximity oscillations of complement receptor type 4 and uroki-
nase receptors on migrating neutrophils are linked with signal
transduction/metabolic oscillations. Biophys. J. 73:1777–1784.
Kindzelskii, A.L., M.-J. Zhou, R.P. Haugland, and H.R. Petty. 1998.
Oscillatory pericellular proteolysis and oxidant deposition dur-
ing neutrophil migration. Biophys. J. 74:90–97.
Kindzelskii, A.L., J.-B. Huang, T. Chaiworapongsa, Y.M. Kim, R.
Romero, and H.R. Petty. 2002. Pregnancy alters glucose-6-phos-
phate dehydrogenase trafﬁcking, cell metabolism and oxidant
release of maternal neutrophils. J. Clin. Invest. 110:1801–1811.
McLaren, M.J., G. Inana, and C.Y. Li. 1993. Double ﬂuorescent vital
assay of phagocytosis by cultured retinal pigment epithelial cells.
Invest. Ophthalmol. Vis. Sci. 34:317–326.
Medzhitov, R., P. Preston-Hurlburt, and C.A. Janeway. 1997. A hu-
man homologue of the Drosophila Toll protein signals activation
of adaptive immunity. Nature. 388:394–397.
Messer, A., J. Plummer, M.C. MacMillen, and W.N. Frankel. 1995.
Genetics of primary and timing effects in the mnd mouse. Am. J.
Med. Genet. 57:361–364.
Messer, A., K. Manley, and J.A. Plummer. 1999. An early-onset con-
genic strain of the motor neuron degeneration (mnd) mouse.
Mol. Genet. Metab. 66:393–397.
Miceli, M.V., M.R. Liles, and D.A. Newsome. 1994. Evaluation of ox-
idative processes in human pigment epithelial cells associated
with retinal outer segment phagocytosis. Exp. Cell Res. 214:242–
249.
Olsen, L.F., U. Kummer, A.L. Kindzelskii, and H.R. Petty. 2003. A
model of the oscillatory metabolism of activated neutrophils. Bio-
phys. J. 84:69–81.
Petty, H.R. 2001. Neutrophil oscillations: temporal and spatiotem-
poral aspects of cell behavior. Immunol. Res. 23:85–94.
Petty, H.R. 2003. Detection of cytokine signal transduction cross-
talk in leukocyte activation. In Methods in Molecular Biology.
Human Cytokine Protocols. Vol. 249. M. de Ley, editor. Humana
Press, Totowa, NJ. 219–227.
Petty, H.R., J.W. Francis, and C.L. Anderson. 1989. Cell surface dis-
tribution of Fc receptors II and III on living human neutrophils
before and during antibody-dependent cellular cytotoxicity. J.
Cell. Physiol. 141:598–605.
Petty, H.R., R.G. Worth, and R.F. Todd III. 2002. Interactions of in-
tegrins with their partner proteins in leukocyte membranes. Im-
munol. Res. 25:75–95.
Petty, H.R., V.M. Elner, S.G. Elner, B.A. Hughes, and A.L. Kindzel-
skii. 2003. Toll-like receptor 4 (TLR4) on RPE cells participates
in transmembrane signaling in response to photoreceptor outer
segments. Invest. Ophthalmol. Vis. Sci. 44(Suppl.):370.
Remer, K.A., M. Brcic, and T.W. Jungi. 2003. Toll-like receptor-4 is
involved in eliciting an LPS-induced oxidative burst in neutro-
phils. Immunol. Lett. 85:75–80.
Schuster, J.M., and P.S. Nelson. 2000. Toll receptors: an expanding
role in our understanding of human disease. J. Leukoc. Biol. 67:
767–773.
Shimazu, R., S. Akashi, H. Ogata, Y. Nagai, K. Fukudome, K. Miy-
ake, and M. Kimoto. 1999. MD-2, a molecule that confers lipo-
polysaccharide responsiveness on Toll-like receptor 4. J. Exp.
Med. 189:1777–1782.
Song, P.I., T.A. Abraham, Y. Park, A.S. Zivony, B. Harten, H.F. Edel-
hauser, S.L. Ward, C.A. Armstrong, and J.C. Ansel. 2001. The ex-
pression of functional LPS receptor proteins CD14 and toll-like
receptor 4 in human corneal cells. Invest. Ophthalmol. Vis. Sci. 42:
2867–2877.
Tabeta, K., K. Yamazaki, S. Akashi, K. Miyake, H. Kumada, T. Ume-
moto, and H. Yoshie. 2000. Toll-like receptors confer responsive-
ness to lipopolysaccharide from Porphyromonas gingivalis in hu-
man gingival ﬁbroblasts. Infect. Immun. 68:3731–3735.
Tate, D.J., Jr., M.V. Miceli, and D.A. Newsome. 1995. Phagocytosis
and H2O2 induce catalase and metallothionein gene expression
in human retinal pigment epithelial cells. Invest. Ophthalmol. Vis.
Sci. 36:1271–1279.
Termeer, C., F. Benedix, J. Sleeman, C. Fieber, U. Voith, T. Ahrens,
K. Miyake, M. Freudenberg, C. Galanos, and J.C. Simon. 2002.
Oligosaccharides of hyaluronan activate dendritic cells via toll-
like receptor 4. J. Exp. Med. 195:99–111.
Uhl, R., H. Desel, N. Ryba, and R. Wagner. 1987. A simple and
rapid procedure for the isolation of intact bovine rod outer seg-
ments (ROS). J. Biochem. Biophys. Methods. 14:127–138.
Vogel, S., M.J. Hirschfeld, and P.Y. Perera. 2001. Signal integration
in lipopolysaccharide (LPS)-stimulated murine macrophages. J.
Endotoxin Res. 7:237–241.
Werling, D., J.C. Hope, C.J. Howard, and T.W. Jungi. 2004. Differ-
ential production of cytokines, reactive oxygen and nitrogen by
bovine macrophages and dendritic cells stimulated with Toll-like
receptor agonists. Immunology. 111:41–52.
Wu, G.S., and N.A. Rao. 1999. Activation of NADPH oxidase by
docosahexaenoic acid hydroperoxide and its inhibition by a
novel retinal pigment epithelial protein. Invest. Ophthalmol. Vis.
Sci. 40:831–839.